Growth Metrics

Eli Lilly (LLY) Inventory Average (2016 - 2025)

Historic Inventory Average for Eli Lilly (LLY) over the last 17 years, with Q3 2025 value amounting to $11.6 billion.

  • Eli Lilly's Inventory Average rose 6637.04% to $11.6 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $11.6 billion, marking a year-over-year increase of 6637.04%. This contributed to the annual value of $6.7 billion for FY2024, which is 3252.67% up from last year.
  • As of Q3 2025, Eli Lilly's Inventory Average stood at $11.6 billion, which was up 6637.04% from $10.2 billion recorded in Q2 2025.
  • Eli Lilly's Inventory Average's 5-year high stood at $11.6 billion during Q3 2025, with a 5-year trough of $3.7 billion in Q2 2021.
  • Over the past 5 years, Eli Lilly's median Inventory Average value was $4.7 billion (recorded in 2023), while the average stood at $5.6 billion.
  • In the last 5 years, Eli Lilly's Inventory Average dropped by 2.33% in 2022 and then surged by 6637.04% in 2025.
  • Eli Lilly's Inventory Average (Quarter) stood at $3.9 billion in 2021, then increased by 4.46% to $4.1 billion in 2022, then surged by 31.12% to $5.3 billion in 2023, then surged by 40.98% to $7.5 billion in 2024, then soared by 54.12% to $11.6 billion in 2025.
  • Its Inventory Average was $11.6 billion in Q3 2025, compared to $10.2 billion in Q2 2025 and $8.5 billion in Q1 2025.